ALKBH1 Drives Tumorigenesis and Drug Resistance via tRNA-decoding Reprogramming and Codon-biased Translation
- 4 August 2025
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 15 (11) , 2298-2325
Abstract
Cancer cells utilize codon-biased translation to fuel tumorigenesis and drug resistance; however, underlying mechanisms remain poorly understood. In this study, we show that ALKBH1 is overexpressed in acute myeloid leukemia (AML) and essential for leukemia stem cell/leukemia-initiating cell self-renewal and AML development/maintenance but dispensable for normal hematopoiesis. ALKBH1 enhances mitochondrial assembly/function and oxidative phosphorylation, crucial for AML survival/proliferation and resistance to venetoclax, a potent BCL2 inhibitor and widely used first-line targeted therapy for AML in the clinic. Mechanistically, ALKBH1 catalyzes 5-formylcytosine at tRNA wobble positions, reprograming decoding and facilitating codon-biased translation, a mechanism we term “epitranslatomic Midas touch,” which in turn drives leukemogenesis and drug resistance by promoting the synthesis of key oncogenic proteins like WDR43. Targeting ALKBH1, particularly together with venetoclax, exhibited potent antileukemia efficacy in preclinical models with favorable safety profiles. Collectively, our findings elucidate ALKBH1’s pivotal role in codon-biased translation and tumorigenesis and propose a novel therapeutic strategy for cancer treatment. Significance: This study uncovers that ALKBH1-driven tRNA-decoding reprogramming and codon-biased translation, termed “epitranslatomic Midas touch,” is crucial for leukemogenesis, leukemia stem cell/leukemia-initiating cell self-renewal, mitochondria structure/function, and resistance to venetoclax. Targeting ALKBH1, especially in combination with venetoclax, offers a promising therapeutic strategy to combat drug resistance in AML and potentially other ALKBH1-overexpressing cancers.Keywords
All Related Versions
Funding Information
- National Institutes of Health (R01 CA280389, R01 CA271497, R01 CA243386, U01 CA305196, R01 CA236399)
This publication has 105 references indexed in Scilit:
- Methods for Monitoring Mitophagy Using mt-Keima2024
- The m5C methyltransferase NSUN2 promotes codon‐dependent oncogenic translation by stabilising tRNA in anaplastic thyroid cancerClinical and Translational Medicine, 2023
- Primary Human Leukemia Stem Cell (LSC) Isolation and Characterization2023
- Demethyltransferase AlkBH1 substrate diversity and relationship to human diseasesMolecular Biology Reports, 2021
- The effects of codon bias and optimality on mRNA and protein regulationCellular and Molecular Life Sciences, 2020
- The role of mitochondrial proteases in leukemic cells and leukemic stem cellsStem Cells Translational Medicine, 2020
- ALKBH1 deficiency leads to loss of homeostasis in human diploid somatic cellsProtein & Cell, 2020
- A Transgenic Core Facility’s Experience in Genome Editing Revolution2017
- Scalable Isolation of Mammalian Mitochondria for Nucleic Acid and Nucleoid Analysis2016
- Processing Biological Tissues for Ultrastructural Study2007